Matches in Wikidata for { <http://www.wikidata.org/entity/Q73404031> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q73404031 description "article scientifique publié en 2000" @default.
- Q73404031 description "articolo scientifico (pubblicato il 2000)" @default.
- Q73404031 description "artikull shkencor i botuar më 01 janar 2000" @default.
- Q73404031 description "artículu científicu espublizáu en xineru de 2000" @default.
- Q73404031 description "im Januar 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73404031 description "scientific article published on 01 January 2000" @default.
- Q73404031 description "wetenschappelijk artikel" @default.
- Q73404031 description "wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch" @default.
- Q73404031 description "наукова стаття, опублікована в січні 2000" @default.
- Q73404031 name "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 name "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 name "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 type Item @default.
- Q73404031 label "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 label "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 label "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 prefLabel "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 prefLabel "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 prefLabel "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 P1433 Q73404031-B8FC3840-34E0-4CCB-9F73-BAB9E5C890C6 @default.
- Q73404031 P1476 Q73404031-63C5BDDF-A5E1-4D79-978F-47893E334C41 @default.
- Q73404031 P2093 Q73404031-21BCC92B-F904-43FC-85A1-2E6DA0D1547A @default.
- Q73404031 P2093 Q73404031-2381CDDB-216C-4AF9-BD3A-17588B47D738 @default.
- Q73404031 P2093 Q73404031-2EEF2B98-240D-4F2D-A21F-81B620AD8C82 @default.
- Q73404031 P2093 Q73404031-5637F603-5860-4CB1-B481-0F554D5D4885 @default.
- Q73404031 P2093 Q73404031-73F4445F-3E82-4AA3-8D57-CC33A8E75B12 @default.
- Q73404031 P2093 Q73404031-7E062365-5CA2-4033-9F6D-1D5ECCEA58D3 @default.
- Q73404031 P2093 Q73404031-82AACA33-D1EC-49D3-B29C-7BFA9405D14D @default.
- Q73404031 P2093 Q73404031-90E638E1-4ED6-40E5-8FB4-2CD68751EDC6 @default.
- Q73404031 P2093 Q73404031-966BD36F-963F-462A-8DDE-32BE12FCB5CE @default.
- Q73404031 P2093 Q73404031-B685C5C8-3D15-48F2-B64F-C6D07B564042 @default.
- Q73404031 P2093 Q73404031-CB7A457A-DDE0-4F55-85A9-6BDDA7285650 @default.
- Q73404031 P2093 Q73404031-D1701170-07FF-4A48-8BBD-5A8D1F447DF2 @default.
- Q73404031 P2093 Q73404031-F9F9EF60-BAE8-476B-B629-E896BB09D206 @default.
- Q73404031 P304 Q73404031-478435F2-248B-4385-8995-52475BD9153B @default.
- Q73404031 P31 Q73404031-312E13F4-A222-4D8D-A858-ED29127835A4 @default.
- Q73404031 P407 Q73404031-CF88B3E7-B786-49C4-B5F5-CB67D1BD15AB @default.
- Q73404031 P433 Q73404031-DFF79759-4459-4933-A9D0-C0C4E88877A0 @default.
- Q73404031 P478 Q73404031-93AB2B02-B20A-4617-AAB3-BDCE33643858 @default.
- Q73404031 P577 Q73404031-CDFC85B6-7C1E-4F57-A1DE-8281A1C3391E @default.
- Q73404031 P698 Q73404031-A7491D4E-63ED-46E6-B951-259B75289C6E @default.
- Q73404031 P921 Q73404031-61B89550-F8C9-4F76-AE39-66F450CE6CD9 @default.
- Q73404031 P921 Q73404031-A108A062-49EE-4F55-89D4-9BF8388D945F @default.
- Q73404031 P921 Q73404031-CE85BDF4-3597-4DA8-9FB7-07DEF3AFE303 @default.
- Q73404031 P698 10656433 @default.
- Q73404031 P1433 Q332253 @default.
- Q73404031 P1476 "A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors" @default.
- Q73404031 P2093 "C Brassinne" @default.
- Q73404031 P2093 "D de Valeriola" @default.
- Q73404031 P2093 "E Van Den Neste" @default.
- Q73404031 P2093 "F Lefresne-Soulas" @default.
- Q73404031 P2093 "H Bleiberg" @default.
- Q73404031 P2093 "H Wythouck" @default.
- Q73404031 P2093 "I Cazenave" @default.
- Q73404031 P2093 "J Kerger" @default.
- Q73404031 P2093 "J Selleslags" @default.
- Q73404031 P2093 "M Piccart" @default.
- Q73404031 P2093 "P Hennebert" @default.
- Q73404031 P2093 "S Bartholomeus" @default.
- Q73404031 P2093 "Z Kusenda" @default.
- Q73404031 P304 "64-71" @default.
- Q73404031 P31 Q13442814 @default.
- Q73404031 P407 Q1860 @default.
- Q73404031 P433 "1" @default.
- Q73404031 P478 "6" @default.
- Q73404031 P577 "2000-01-01T00:00:00Z" @default.
- Q73404031 P698 "10656433" @default.
- Q73404031 P921 Q238512 @default.
- Q73404031 P921 Q323936 @default.
- Q73404031 P921 Q420436 @default.